azathioprine has been researched along with Genetic Predisposition in 55 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations." | 7.75 | Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009) |
"Azathioprine (AZA) is a thiopurine prodrug which is widely used in patients with inflammatory bowel disease (IBD)." | 5.42 | The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. ( Bi, H; Ding, L; Gao, X; Hu, P; Huang, M; Liu, H; Zhang, F; Zhang, Y, 2015) |
"Our work supports the strong evidence that individuals with TPMT variant homozygosity are at high risk of severe neutropenia, whereas TPMT heterozygotes are not at increased risk of ADRs at standard doses of azathioprine." | 5.15 | A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. ( Alder, JE; Andrews, J; Bruce, I; Elles, R; Elliott, RA; Fargher, E; Griffiths, CE; Heise, M; Houston, JB; Newman, WG; Ollier, WE; Payne, D; Payne, K; Pushpakom, S; Qasim, F; Ramsden, SC; Ray, DW; Roberts, SA; Shaffer, J; Sidgwick, GP; Tricker, K, 2011) |
" The thiopurine drugs, azathioprine and 6-mercaptopurine, are commonly used to maintain remission in Crohn's disease and ulcerative colitis; however, the use of these drugs may be limited by the development of pancreatitis in some individuals." | 4.91 | Thiopurine-induced pancreatitis in inflammatory bowel diseases. ( Day, AS; Ledder, O; Lemberg, DA, 2015) |
"Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine or mercaptopurine." | 3.80 | HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. ( Ahmad, T; Andrews, JM; Annese, V; Bampton, P; Barnardo, M; Bell, S; Bewshea, CM; Chen, M; Cole, A; Connor, SJ; Creed, T; Cummings, FR; D'Amato, M; Daneshmend, TK; Dubois, PC; Fedorak, RN; Florin, TH; Gaya, DR; Greig, E; Halfvarson, J; Hart, A; Heap, GA; Holden, AL; Irving, PM; Jones, G; Karban, A; Lawrance, IC; Lee, JC; Lees, C; Lev-Tzion, R; Lindsay, JO; Mansfield, J; Mawdsley, J; Mazhar, Z; Orchard, TR; Parkes, M; Parnell, K; Radford-Smith, G; Reffitt, D; Rossjohn, J; Russell, RK; Satchwell, JB; Satsangi, J; Silverberg, MS; Singh, A; So, K; Sturniolo, GC; Tremelling, M; Tsianos, EV; van Heel, DA; Vivian, JP; Walsh, A; Watermeyer, G; Weedon, MN; Weersma, RK; Zeissig, S, 2014) |
"An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations." | 3.75 | Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009) |
"Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy." | 3.75 | Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity. ( Bartos, M; Bartosova, L; Batovsky, M; Chylkova, A; Dvorackova, D; Hosek, J; Kolorz, M; Zboril, V, 2009) |
"Of all azathioprine treated patients, 11 experienced an adverse event for which azathioprine was stopped: pancreatitis (n = 4), leucopenia (n = 2) and 'general malaise' (n = 5)." | 3.73 | Pharmacogenetics of thiopurine therapy in paediatric IBD patients. ( Benninga, MA; De Ridder, L; Escher, JC; Hommes, DW; Stokkers, PC; Van der Woude, JC; Van Deventer, HJ; Van Dieren, JM; Van Vuuren, AJ, 2006) |
"Azathioprine, off-label used long time ago to treat multiple sclerosis (MS) patients, has recently received approval from the Spanish Medicine Agency (Agencia Española del Medicamento) in relapsing-remitting (RR) forms of this condition." | 3.71 | [Hypomethylation and multiple sclerosis, the susceptibility factor?]. ( Cara Terribas, CJ; González Guijarro, L, 2002) |
"The International Autoimmune Hepatitis Group (IAIHG) has devised diagnostic scoring systems to help in comparative studies and clinical practice." | 2.53 | Cutting edge issues in autoimmune hepatitis. ( Krawitt, EL; Liberal, R; Manns, MP; Mieli-Vergani, G; Vergani, D; Vierling, JM, 2016) |
"Autoimmune hepatitis is a chronic inflammatory disease of the liver with a dismal prognosis when left untreated." | 2.46 | Autoimmune hepatitis. ( Strassburg, CP, 2010) |
"Pediatric ulcerative colitis tends to present with more severe and more extensive involvement than in adults." | 2.44 | IBD in children: lessons for adults. ( Haller, CA; Markowitz, J, 2007) |
"Autoimmune hepatitis has a global distribution and affects all ages." | 2.41 | Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. ( Al-Khalidi, JA; Czaja, AJ, 2001) |
" NUDT15 variants are associated with thiopurine-induced adverse events, particularly in Asians." | 1.56 | Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis. ( Kakuta, Y; Kawata, Y; Okamoto, D; Sato, H; Terai, S; Tominaga, K; Tomiyoshi, K; Yokoyama, J, 2020) |
"The included patients had either Crohn's disease (54; 65." | 1.51 | Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. ( Akiyama, S; Arai, M; Fujii, T; Fukuda, K; Hamada, S; Hashiguchi, M; Hisamatsu, T; Iwao, Y; Kanai, T; Kiyohara, H; Matsuoka, K; Mizuno, S; Mochizuki, M; Motobayashi, M; Nagahori, M; Naganuma, M; Nanki, K; Ogata, H; Ohtsuka, K; Saito, E; Shimizu, M; Sugimoto, S; Suzuki, K; Takenaka, K; Watanabe, M, 2019) |
"Despite NUDT15 variants showing significant association with thiopurine-induced adverse events (AEs) in Asians, it remains unclear which variants of NUDT15 or whether additional genetic variants should be tested to predict AEs." | 1.48 | NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. ( Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S, 2018) |
" The median dosage for NUDT15 c." | 1.46 | Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis. ( Cao, Q; Chao, K; Gao, X; Hu, P; Huang, M; Huang, Y; Huang, Z; Lan, P; Liang, J; Lin, L; Qian, J; Sun, Y; Wang, X; Wu, K; Xue, X; Yang, H; Zhang, Y; Zhu, X, 2017) |
"Thiopurine-induced severe hair loss causes cosmetic problems, and it takes a long time to recover." | 1.43 | NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. ( Endo, K; Kakuta, Y; Kimura, T; Kinouchi, Y; Kuroha, M; Naito, T; Negoro, K; Onodera, M; Shiga, H; Shimosegawa, T, 2016) |
" The aim of the study was to investigate frequencies of TPMT and ITPA polymorphisms in Lithuanian IBD patients and analyze their association with AZA-related adverse events." | 1.43 | TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. ( Denapiene, G; Jonaitis, L; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Skieceviciene, J; Steponaitiene, R; Survilaite, S; Valantinas, J; Varkalaite, G, 2016) |
"Thiopurine-induced leukopenia is a relatively common adverse event related to thiopurine medication in Korean pediatric Crohn's disease." | 1.43 | NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease. ( Hwang, EH; Kang, B; Kim, SY; Lee, YJ; Park, JH; Shin, JH, 2016) |
"Azathioprine (AZA) is a thiopurine prodrug which is widely used in patients with inflammatory bowel disease (IBD)." | 1.42 | The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. ( Bi, H; Ding, L; Gao, X; Hu, P; Huang, M; Liu, H; Zhang, F; Zhang, Y, 2015) |
"A total of 174 patients with ulcerative colitis, 99 women and 75 men, were included." | 1.40 | IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. ( Brito, M; Correia, LA; Cravo, ML; de Deus, JR; Ferreira, PA; Maio, RF; Ministro, P; Moura-Santos, P; Peixe, P; Sousa, P; Tavares, L; Velho, S; Velosa, JF, 2014) |
"Crohn's disease is rare in South African black people and primary sclerosing cholangitis (PSC) is also rare in black patients with IBD, from South Africa." | 1.38 | Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women. ( Bezuidenhout, E; Bosch, FJ; Buchel, OC; de K Grundling, H; de Vries, CS; Fevery, J; Janse van Rensburg, J; Middlecote, BD; van Zyl, JH, 2012) |
"Azathioprine is an immunosuppressant prescribed for the treatment of inflammatory conditions and after organ transplantation." | 1.34 | Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. ( Bruce, I; Elliott, R; Fargher, EA; Newman, W; Payne, K; Roberts, SA; Shaffer, JL; Tricker, K, 2007) |
"Genetic susceptibility to type 1 autoimmune hepatitis is indicated by a preponderance of female subjects and strong associations with human leukocyte antigens (HLA) DRB1*0301 and DRB1*0401." | 1.31 | Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. ( Agarwal, K; Czaja, AJ; Donaldson, PT; Jones, DE, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 23 (41.82) | 29.6817 |
2010's | 29 (52.73) | 24.3611 |
2020's | 3 (5.45) | 2.80 |
Authors | Studies |
---|---|
Yang, J | 2 |
Wang, P | 1 |
Qin, Z | 1 |
Jia, M | 1 |
Zhang, C | 1 |
Tian, X | 1 |
Zheng, Y | 1 |
Zhang, A | 1 |
Zhang, X | 1 |
Liu, S | 1 |
Tomiyoshi, K | 1 |
Sato, H | 1 |
Tominaga, K | 1 |
Kawata, Y | 1 |
Okamoto, D | 2 |
Kakuta, Y | 3 |
Yokoyama, J | 1 |
Terai, S | 1 |
Moreno Moraleda, I | 1 |
Lázaro Sáez, M | 1 |
Diéguez Castillo, C | 1 |
Hernández Martínez, Á | 1 |
Sakaguchi, H | 2 |
Mizuochi, T | 1 |
Haruta, M | 1 |
Takase, R | 1 |
Yoshida, S | 1 |
Yamashita, Y | 1 |
Nishikomori, R | 1 |
Chao, K | 1 |
Wang, X | 1 |
Cao, Q | 1 |
Qian, J | 1 |
Wu, K | 1 |
Zhu, X | 1 |
Yang, H | 1 |
Liang, J | 1 |
Lin, L | 1 |
Huang, Z | 1 |
Zhang, Y | 2 |
Huang, Y | 1 |
Sun, Y | 1 |
Xue, X | 1 |
Huang, M | 2 |
Hu, P | 2 |
Lan, P | 1 |
Gao, X | 2 |
Adalı, G | 1 |
Ersoy Tunalı, N | 1 |
Yorulmaz, E | 1 |
Tiryakioğlu, NO | 1 |
Mungan, SG | 1 |
Ulaşoğlu, C | 1 |
Yılmaz Enç, F | 1 |
Tuncer, İ | 1 |
Yang, X | 1 |
Xu, H | 1 |
Yang, L | 1 |
Kawai, Y | 1 |
Takagawa, T | 1 |
Ikeya, K | 1 |
Sakuraba, H | 1 |
Nishida, A | 1 |
Nakagawa, S | 1 |
Miura, M | 1 |
Toyonaga, T | 1 |
Onodera, K | 1 |
Shinozaki, M | 1 |
Ishiguro, Y | 1 |
Mizuno, S | 2 |
Takahara, M | 1 |
Yanai, S | 1 |
Hokari, R | 1 |
Nakagawa, T | 1 |
Araki, H | 1 |
Motoya, S | 1 |
Naito, T | 2 |
Moroi, R | 1 |
Shiga, H | 2 |
Endo, K | 2 |
Kobayashi, T | 1 |
Naganuma, M | 2 |
Hiraoka, S | 1 |
Matsumoto, T | 1 |
Nakamura, S | 1 |
Nakase, H | 1 |
Hisamatsu, T | 2 |
Sasaki, M | 1 |
Hanai, H | 1 |
Andoh, A | 1 |
Nagasaki, M | 1 |
Kinouchi, Y | 2 |
Shimosegawa, T | 2 |
Masamune, A | 1 |
Suzuki, Y | 1 |
Weidinger, S | 1 |
Beck, LA | 1 |
Bieber, T | 1 |
Kabashima, K | 1 |
Irvine, AD | 1 |
Akiyama, S | 1 |
Matsuoka, K | 1 |
Fukuda, K | 1 |
Hamada, S | 1 |
Shimizu, M | 1 |
Nanki, K | 1 |
Kiyohara, H | 1 |
Arai, M | 1 |
Sugimoto, S | 1 |
Iwao, Y | 1 |
Ogata, H | 1 |
Motobayashi, M | 1 |
Suzuki, K | 1 |
Takenaka, K | 1 |
Fujii, T | 1 |
Saito, E | 1 |
Nagahori, M | 1 |
Ohtsuka, K | 1 |
Mochizuki, M | 1 |
Watanabe, M | 1 |
Hashiguchi, M | 1 |
Kanai, T | 1 |
Buchel, OC | 1 |
Bosch, FJ | 1 |
Janse van Rensburg, J | 1 |
Bezuidenhout, E | 1 |
de Vries, CS | 1 |
van Zyl, JH | 1 |
Middlecote, BD | 1 |
de K Grundling, H | 1 |
Fevery, J | 1 |
Cravo, ML | 1 |
Ferreira, PA | 1 |
Sousa, P | 1 |
Moura-Santos, P | 1 |
Velho, S | 1 |
Tavares, L | 1 |
de Deus, JR | 1 |
Ministro, P | 1 |
Peixe, P | 1 |
Correia, LA | 1 |
Velosa, JF | 1 |
Maio, RF | 1 |
Brito, M | 1 |
Galatola, M | 1 |
Miele, E | 1 |
Strisciuglio, C | 1 |
Paparo, L | 1 |
Rega, D | 1 |
Delrio, P | 1 |
Duraturo, F | 1 |
Martinelli, M | 1 |
Rossi, GB | 1 |
Staiano, A | 1 |
Izzo, P | 1 |
De Rosa, M | 1 |
Heap, GA | 1 |
Weedon, MN | 1 |
Bewshea, CM | 1 |
Singh, A | 1 |
Chen, M | 1 |
Satchwell, JB | 1 |
Vivian, JP | 1 |
So, K | 1 |
Dubois, PC | 1 |
Andrews, JM | 1 |
Annese, V | 1 |
Bampton, P | 1 |
Barnardo, M | 1 |
Bell, S | 1 |
Cole, A | 1 |
Connor, SJ | 1 |
Creed, T | 1 |
Cummings, FR | 1 |
D'Amato, M | 1 |
Daneshmend, TK | 1 |
Fedorak, RN | 1 |
Florin, TH | 2 |
Gaya, DR | 1 |
Greig, E | 1 |
Halfvarson, J | 1 |
Hart, A | 1 |
Irving, PM | 1 |
Jones, G | 1 |
Karban, A | 2 |
Lawrance, IC | 1 |
Lee, JC | 1 |
Lees, C | 2 |
Lev-Tzion, R | 1 |
Lindsay, JO | 1 |
Mansfield, J | 1 |
Mawdsley, J | 1 |
Mazhar, Z | 1 |
Parkes, M | 1 |
Parnell, K | 1 |
Orchard, TR | 1 |
Radford-Smith, G | 1 |
Russell, RK | 1 |
Reffitt, D | 1 |
Satsangi, J | 2 |
Silverberg, MS | 1 |
Sturniolo, GC | 1 |
Tremelling, M | 1 |
Tsianos, EV | 1 |
van Heel, DA | 1 |
Walsh, A | 1 |
Watermeyer, G | 1 |
Weersma, RK | 1 |
Zeissig, S | 1 |
Rossjohn, J | 1 |
Holden, AL | 1 |
Ahmad, T | 1 |
Ledder, O | 1 |
Lemberg, DA | 1 |
Day, AS | 1 |
Onodera, M | 1 |
Kuroha, M | 1 |
Kimura, T | 1 |
Negoro, K | 1 |
Liu, H | 1 |
Ding, L | 1 |
Zhang, F | 1 |
Bi, H | 1 |
Steponaitiene, R | 1 |
Kupcinskas, J | 1 |
Survilaite, S | 1 |
Varkalaite, G | 1 |
Jonaitis, L | 1 |
Kiudelis, G | 1 |
Denapiene, G | 1 |
Valantinas, J | 1 |
Skieceviciene, J | 1 |
Kupcinskas, L | 1 |
Lee, YJ | 1 |
Hwang, EH | 1 |
Park, JH | 1 |
Shin, JH | 1 |
Kang, B | 1 |
Kim, SY | 1 |
Liberal, R | 1 |
Krawitt, EL | 1 |
Vierling, JM | 1 |
Manns, MP | 1 |
Mieli-Vergani, G | 1 |
Vergani, D | 1 |
Yamamoto-Furusho, JK | 1 |
Kaser, A | 1 |
Tilg, H | 1 |
Oflazer, PS | 1 |
Gundesli, H | 1 |
Zorludemir, S | 1 |
Sabuncu, T | 1 |
Dincer, P | 1 |
Takatsu, N | 1 |
Matsui, T | 1 |
Murakami, Y | 1 |
Ishihara, H | 1 |
Hisabe, T | 1 |
Nagahama, T | 1 |
Maki, S | 1 |
Beppu, T | 1 |
Takaki, Y | 1 |
Hirai, F | 1 |
Yao, K | 1 |
Weiss, B | 1 |
Lebowitz, O | 1 |
Fidder, HH | 1 |
Maza, I | 1 |
Levine, A | 1 |
Shaoul, R | 1 |
Reif, S | 1 |
Bujanover, Y | 1 |
Kolorz, M | 2 |
Bartosova, L | 2 |
Hosek, J | 1 |
Dvorackova, D | 1 |
Chylkova, A | 1 |
Zboril, V | 2 |
Batovsky, M | 2 |
Bartos, M | 2 |
Jolobe, O | 1 |
Nagy, ZB | 1 |
Csanád, M | 1 |
Tóth, K | 1 |
Börzsönyi, B | 1 |
Demendi, C | 1 |
Rigó, J | 1 |
Joó, JG | 1 |
Strassburg, CP | 2 |
Ernst, A | 1 |
Andersen, V | 1 |
Ostergaard, M | 1 |
Jacobsen, BA | 1 |
Pedersen, IS | 1 |
Drewes, AM | 1 |
Okkels, H | 1 |
Krarup, HB | 1 |
Newman, WG | 1 |
Payne, K | 2 |
Tricker, K | 2 |
Roberts, SA | 2 |
Fargher, E | 1 |
Pushpakom, S | 1 |
Alder, JE | 1 |
Sidgwick, GP | 1 |
Payne, D | 1 |
Elliott, RA | 1 |
Heise, M | 1 |
Elles, R | 1 |
Ramsden, SC | 1 |
Andrews, J | 1 |
Houston, JB | 1 |
Qasim, F | 1 |
Shaffer, J | 1 |
Griffiths, CE | 1 |
Ray, DW | 1 |
Bruce, I | 2 |
Ollier, WE | 1 |
Büning, C | 1 |
Geissler, N | 1 |
Prager, M | 1 |
Sturm, A | 1 |
Baumgart, DC | 1 |
Büttner, J | 1 |
Bühner, S | 1 |
Haas, V | 1 |
Lochs, H | 1 |
Murakami, M | 1 |
Shimane, K | 1 |
Takahashi, H | 1 |
Tomiyama, J | 1 |
Nagashima, M | 1 |
Vajro, P | 1 |
Paolella, G | 1 |
Wroblova, K | 1 |
Suchankova, J | 1 |
Ulicny, B | 1 |
Pav, I | 1 |
Roberts, RL | 1 |
Barclay, ML | 1 |
Pender, MP | 1 |
Wolfe, NP | 1 |
Ho, GT | 1 |
Merk, HF | 1 |
Allorge, D | 1 |
Hamdan, R | 1 |
Broly, F | 1 |
Libersa, C | 1 |
Colombel, JF | 1 |
De Ridder, L | 1 |
Van Dieren, JM | 1 |
Van Deventer, HJ | 1 |
Stokkers, PC | 1 |
Van der Woude, JC | 1 |
Van Vuuren, AJ | 1 |
Benninga, MA | 1 |
Escher, JC | 1 |
Hommes, DW | 1 |
Duley, JA | 1 |
Marinaki, AM | 1 |
Arenas, M | 1 |
Murray, KF | 1 |
Tamori, A | 1 |
Shinzaki, M | 1 |
Kosaka, S | 1 |
Hayashi, T | 1 |
Iwai, S | 1 |
Enomoto, M | 1 |
Habu, D | 1 |
Kawada, N | 1 |
Hino, M | 1 |
Shiomi, S | 1 |
Nishiguchi, S | 1 |
Fargher, EA | 1 |
Newman, W | 1 |
Elliott, R | 1 |
Shaffer, JL | 1 |
Camilleri, M | 1 |
Saito, YA | 1 |
Ranganathan, P | 1 |
Haller, CA | 1 |
Markowitz, J | 1 |
Agarwal, K | 1 |
Czaja, AJ | 2 |
Jones, DE | 1 |
Donaldson, PT | 1 |
Sebbag, L | 1 |
Boucher, P | 1 |
Davelu, P | 1 |
Boissonnat, P | 1 |
Champsaur, G | 1 |
Ninet, J | 1 |
Dureau, G | 1 |
Obadia, JF | 1 |
Vallon, JJ | 1 |
Delaye, J | 1 |
Al-Khalidi, JA | 1 |
Cara Terribas, CJ | 1 |
González Guijarro, L | 1 |
Kuehn, F | 1 |
Klar, E | 1 |
Bliemeister, A | 1 |
Linnebacher, M | 1 |
Török, HP | 1 |
Glas, J | 1 |
Lohse, P | 1 |
Folwaczny, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Abrocitinib Treatment of Moderate to Severe Atopic Dermatitis on Skin Barrier Function[NCT05140239] | 20 participants (Anticipated) | Observational | 2022-09-01 | Recruiting | |||
A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed[NCT04662619] | 273 participants (Actual) | Interventional | 2020-12-18 | Active, not recruiting | |||
Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis[NCT01783119] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2012-08-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
15 reviews available for azathioprine and Genetic Predisposition
Article | Year |
---|---|
Topics: Administration, Intravenous; Adrenal Cortex Hormones; AIRE Protein; Autoantibodies; Autoimmune Disea | 2021 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestina | 2015 |
Cutting edge issues in autoimmune hepatitis.
Topics: Azathioprine; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis, Autoimmune; H | 2016 |
Autoimmune hepatitis.
Topics: Animals; Azathioprine; Budesonide; Diagnosis, Differential; Drug Therapy, Combination; Genetic Predi | 2010 |
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Biotransformation; Crohn Disease; Drug Hypersensitivity; Drug | 2012 |
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease | 2002 |
Pharmacogenetics and inflammatory bowel disease: progress and prospects.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Drug Therapy, Combination; Female; Fo | 2004 |
[Pharmacogenetics: Important aspects for dermatology].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dapsone; Dermatology; Drug Eruptions; Fluorou | 2005 |
[Autoimmune liver diseases and their overlap syndromes].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath | 2006 |
Pharmacogenomics in gastrointestinal disorders.
Topics: Antineoplastic Agents; Azathioprine; Biotransformation; Colorectal Neoplasms; Gastrointestinal Agent | 2008 |
Pharmacogenomics in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biotransformation; Genetic Predisposition | 2008 |
IBD in children: lessons for adults.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; An | 2007 |
Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
Topics: Age Distribution; Anti-Inflammatory Agents; Azathioprine; Causality; Drug Therapy, Combination; Euro | 2001 |
Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?
Topics: Adaptor Proteins, Signal Transducing; Animals; Clinical Trials as Topic; Crohn Disease; Genetic Pred | 2006 |
1 trial available for azathioprine and Genetic Predisposition
Article | Year |
---|---|
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug-Related Side Effects and Adverse | 2011 |
39 other studies available for azathioprine and Genetic Predisposition
Article | Year |
---|---|
Topics: Adolescent; Adult; Aged; Alleles; Asian People; Azathioprine; Biomarkers; Child; Female; Genetic Pre | 2019 |
Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis.
Topics: Alopecia; Asian People; Azathioprine; Codon; Colitis, Ulcerative; Genetic Predisposition to Disease; | 2020 |
Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
Topics: Adenocarcinoma; Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Colit | 2021 |
Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
Topics: Adolescent; Adult; Aged; Asian People; Azathioprine; Child; Child, Preschool; China; Cohort Studies; | 2017 |
Extracellular matrix protein 1 gene rs3737240 single nucleotide polymorphism is associated with ulcerative colitis in Turkish patients.
Topics: Adult; Alleles; Asian People; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Extracellular | 2017 |
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Di | 2017 |
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition | 2018 |
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Erythrocyte Indic | 2019 |
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women.
Topics: Adult; Alkaline Phosphatase; Azathioprine; Back Pain; Black People; Cholagogues and Choleretics; Cho | 2012 |
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azath | 2014 |
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.
Topics: Adenomatous Polyposis Coli; Age of Onset; Anti-Infective Agents; Azathioprine; beta Catenin; Biomark | 2013 |
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
Topics: Azathioprine; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Geno | 2014 |
NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
Topics: Adult; Alopecia; Anti-Inflammatory Agents; Asian People; Azathioprine; Chi-Square Distribution; Coli | 2016 |
The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Topics: Adolescent; Adult; Alleles; Analysis of Variance; Asian People; Azathioprine; Female; Genetic Predis | 2015 |
TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Topics: Adult; Azathioprine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotyping Technique | 2016 |
NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
Topics: Age Factors; Alopecia; Asian People; Azathioprine; Crohn Disease; Female; Gastrointestinal Agents; G | 2016 |
Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).
Topics: Adult; Age of Onset; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Co | 2009 |
Inflammatory bowel diseases: highlights from the United European Gastroenterology Week 2008.
Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Genetic Predisposition | 2009 |
Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?
Topics: Azathioprine; Calpain; Child; Creatine Kinase; Disease Progression; Dose-Response Relationship, Drug | 2009 |
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents; Asian People; Azathioprine; Chemica | 2009 |
Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Chi- | 2010 |
Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.
Topics: Adult; Alleles; Azathioprine; Female; Genetic Predisposition to Disease; Genotype; Humans; Leukopeni | 2009 |
Beyond these insights there are further applications and future challenges.
Topics: Azathioprine; Crohn Disease; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Me | 2010 |
Current concepts in the genetic diagnostics of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Genetic Predisposition to Disease; HLA-DR | 2010 |
Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population.
Topics: Adolescent; Adult; Arylamine N-Acetyltransferase; Azathioprine; Chronic Disease; Cohort Studies; Den | 2011 |
Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?
Topics: Adult; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Colon; Female; Genetic Predispositio | 2012 |
ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopl | 2013 |
Autoimmune hepatitis: current knowledge.
Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Azathioprine; Child; Cyclosporine; Genetic Pr | 2012 |
Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients.
Topics: Azathioprine; Gastrointestinal Diseases; Gene Expression Regulation; Genetic Predisposition to Disea | 2012 |
ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Gen | 2005 |
Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
Topics: Adolescent; Azathioprine; Chi-Square Distribution; Child; Female; Gene Frequency; Genetic Predisposi | 2006 |
Do ITPA and TPMT genotypes predict the development of side effects to AZA?
Topics: Azathioprine; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Inflammatory Bowe | 2006 |
Autoimmune hepatitis: are we using the right therapy?
Topics: Adolescent; Animals; Azathioprine; Child; Cyclosporine; Disease Models, Animal; Genetic Predispositi | 2007 |
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
Topics: Adult; Aged; Agranulocytosis; Asian People; Azathioprine; Bone Marrow; Female; Gastrointestinal Dise | 2007 |
Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Topics: Attitude of Health Personnel; Azathioprine; Crohn Disease; Dermatology; Dose-Response Relationship, | 2007 |
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Topics: Abatacept; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antig | 2000 |
Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
Topics: Adult; Agranulocytosis; Azathioprine; Bone Marrow; Female; Forecasting; Genetic Predisposition to Di | 2000 |
[Hypomethylation and multiple sclerosis, the susceptibility factor?].
Topics: Autoimmune Diseases; Azathioprine; Genetic Predisposition to Disease; Humans; Immunosuppressive Agen | 2002 |
Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Autoantigens; Case-Control Studies; Female; Frameshift Mutation; Gen | 2015 |